ScreenerHero

CAMX Camurus AB (publ)

STO · SE · Healthcare · Biotechnology · camurus.com
637.00SEK+0.71%Mkt Cap: 3.63B $P/E: 56.27

Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia. The company offers Buvidal, a buprenorphi…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap3.63B USD
Enterprise Value3.08B USD
Revenue (TTM)216.82M USD
Gross Profit201.75M USD
Net Income (TTM)70.36M USD
Revenue/Share38.02 SEK
Last Price637.00 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees316
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)56.27
P/E (Forward)39.51
PEG—
EV/EBITDA39.15
EV/Revenue14.22
P/S15.96
P/B7.73
EPS (TTM)11.32
EPS (Forward)15.39
52W Range
430.8074% of range710.00
52W High710.00 SEK
52W Low430.80 SEK
Profitability
Gross Margin93.11%
Oper. Margin41.66%
EBITDA Margin36.31%
Profit Margin32.47%
ROE17.37%
ROA15.52%
Growth
Revenue Growth3.90%
Earnings Growth-1.50%
Cash Flow & Leverage
Operating CF83.15M USD
CapEx (TTM)13.25M USD
FCF Margin17.87%
FCF Yield1.07%
Net Debt-378.80M USD
Net Debt/EBITDA-4.81
Balance Sheet
Debt/Equity0.03
Current Ratio10.01
Quick Ratio9.35
Book Value/Sh78.65 SEK
Cash/Share68.37 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)793.00 SEK
Upside (mean)+24.5%
Target Range650.00 SEK – 914.00 SEK
650.00+24.5% to mean914.00
# Analysts8
Ownership
Shares Out.59.51M
Float39.45M
Insiders33.12%
Institutions43.80%
Technical
SMA 50608.69 (+4.7%)
SMA 200570.32 (+11.7%)
Beta0.51
S&P 52W Chg14.58%
Avg Vol (30d)79.79K
Avg Vol (10d)81.78K
Technical Indicators
RSI (14)60.8
MACD7.8540
MACD Signal5.5662
MACD Hist.+2.2878
BB Upper646.94 SEK
BB Middle609.95 SEK
BB Lower572.96 SEK
BB Width12.13%
ATR (14)20.03 SEK
Vol Ratio (20d)2.15x